Register for Upcoming Webinar on DEC. 8 @ 11AM
2026 China NMPA Bluebook is here:
In this article we will provide an update on Clinical Evaluation Report (CER) requirements in China by NMPA (CFDA). Furthermore, you will learn about areas
China Med Device and CABA held a quarterly Regulatory Affairs event with CFDA representatives from Beijing in Cambridge, MA on Sunday, December 10. Nearly 50
A dozen branches and agencies of the Chinese central government have launched a cohesive effort to protect intellectual property (IP) of overseas companies and organizations.
Rapidly Growing DNA Sequencing Industry in China According to a market research report by CIConsulting, the market size of China’s DNA sequencing industry will reach
G Medical and China’s Shandong Boletong Information entered a binding MOU (Memorandum of Understanding) for Boletong to distribute G Medical’s call centre cooperation with a
The 8th China International Medical Device Regulatory Forum was held in Hangzhou in August. Xiao Hong, deputy director general of China Food and Drug Administration，